Fig. 3From: Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinomaForest plot of the subgroup analysis according to sample type (tissue and blood), detection method (MSP and others) and sample size (≥ 100 and < 100) for the correlation between RASSF1A promoter hypermethylation with HCC in non-tumor groups and normal groups. No., number; OR, odds ratio; CI, confidence intervalBack to article page